Pulmatrix Statistics
Total Valuation
Pulmatrix has a market cap or net worth of $22.64 million. The enterprise value is $13.12 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, before market open.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pulmatrix has 3.65 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 3.65M |
| Shares Outstanding | 3.65M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 8.50% |
| Float | 3.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.90 |
| Forward PS | n/a |
| PB Ratio | 2.53 |
| P/TBV Ratio | 2.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.68
| Current Ratio | 10.68 |
| Quick Ratio | 10.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -70.96% and return on invested capital (ROIC) is -25.02%.
| Return on Equity (ROE) | -70.96% |
| Return on Assets (ROA) | -20.34% |
| Return on Invested Capital (ROIC) | -25.02% |
| Return on Capital Employed (ROCE) | -79.27% |
| Revenue Per Employee | $3.90M |
| Profits Per Employee | -$4.78M |
| Employee Count | 2 |
| Asset Turnover | 0.36 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +228.04% in the last 52 weeks. The beta is 1.38, so Pulmatrix's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | +228.04% |
| 50-Day Moving Average | 6.68 |
| 200-Day Moving Average | 4.88 |
| Relative Strength Index (RSI) | 46.78 |
| Average Volume (20 Days) | 8,410 |
Short Selling Information
The latest short interest is 25,173, so 0.69% of the outstanding shares have been sold short.
| Short Interest | 25,173 |
| Short Previous Month | 36,921 |
| Short % of Shares Out | 0.69% |
| Short % of Float | 0.69% |
| Short Ratio (days to cover) | 1.23 |
Income Statement
In the last 12 months, Pulmatrix had revenue of $7.81 million and -$9.56 million in losses. Loss per share was -$2.62.
| Revenue | 7.81M |
| Gross Profit | 7.66M |
| Operating Income | -7.15M |
| Pretax Income | -8.85M |
| Net Income | -9.56M |
| EBITDA | -7.04M |
| EBIT | -7.15M |
| Loss Per Share | -$2.62 |
Full Income StatementBalance Sheet
The company has $9.52 million in cash and n/a in debt, giving a net cash position of $9.52 million or $2.61 per share.
| Cash & Cash Equivalents | 9.52M |
| Total Debt | n/a |
| Net Cash | 9.52M |
| Net Cash Per Share | $2.61 |
| Equity (Book Value) | 8.95M |
| Book Value Per Share | 2.45 |
| Working Capital | 8.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.72 million and capital expenditures -$398,000, giving a free cash flow of -$11.11 million.
| Operating Cash Flow | -10.72M |
| Capital Expenditures | -398,000 |
| Free Cash Flow | -11.11M |
| FCF Per Share | -$3.04 |
Full Cash Flow StatementMargins
Gross margin is 98.09%, with operating and profit margins of -91.53% and -122.46%.
| Gross Margin | 98.09% |
| Operating Margin | -91.53% |
| Pretax Margin | -122.46% |
| Profit Margin | -122.46% |
| EBITDA Margin | -90.17% |
| EBIT Margin | -91.53% |
| FCF Margin | n/a |